Skip to main content
. 2022 Aug 4;14(8):e27668. doi: 10.7759/cureus.27668

Table 1. Differentiating features of SS and neuroleptic malignant syndrome.

SS, serotonin syndrome

  Serotonin syndrome Neuroleptic malignant syndrome
Inciting drug Serotonergic agent Dopamine antagonist
Onset Usually < 24 h Gradual onset (days to weeks)
Vitals Hypertension, tachycardia, tachypnea, hyperthermia (<41℃) Hypertension, tachycardia, tachypnea, hyperthermia (>41℃)
Core symptoms Agitation, diarrhea, diaphoresis, tremors Dysphagia, hypersalivation
Neuromuscular signs Hyperreflexia, clonus, mydriasis Bradykinesia, hyporeflexia, lead-pipe rigidity
Lab findings Most commonly no significant lab abnormalities Increase in creatine kinase, leukocytosis, low serum iron